PAI
ARIA

Palo Alto Investors’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Palo Alto Investors’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-2,682,017
Closed -$33.4M – 40
2016
Q4 		$33.4M Buy
2,682,017
+94,400
+4% +$1.14M 1.9% 17
2016
Q3 		$35.4M Buy
2,587,617
+52,500
+2% +$527K 2.06% 16
2016
Q2 		$18.7M Buy
2,535,117
+286,800
+13% +$2.15M 1.42% 20
2016
Q1 		$14.4M Sell
2,248,317
-8,900
-0.4% -$49.9K 1.12% 22
2015
Q4 		$14.1M Buy
2,257,217
+25,500
+1% +$167K 0.79% 25
2015
Q3 		$13M Hold
2,231,717
– – 0.63% 26
2015
Q2 		$18.5M Hold
2,231,717
– – 0.82% 24
2015
Q1 		$18.4M Hold
2,231,717
– – 0.91% 27
2014
Q4 		$15.3M Hold
2,231,717
– – 0.9% 25
2014
Q3 		$12.1M Sell
2,231,717
-43,886
-2% -$256K 0.9% 26
2014
Q2 		$14.5M Sell
2,275,603
-1,183,021
-34% -$8.14M 1.08% 23
2014
Q1 		$27.9M Buy
3,458,624
+17,300
+0.5% +$135K 2.3% 15
2013
Q4 		$23.5M Buy
+3,441,324
New +$18.6M 2.19% 14

Other funds holding ARIA

FPF
FNY Partners Fund New York $185M AUM 32.59% 1-Year Est. Return

Palo Alto Investors's ARIA Position: Q1 2017 in Review

Palo Alto Investors sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 2,682,017 shares — an estimated $33.4M sold.

Palo Alto Investors first reported a position in ARIA in Q4 2013 and held it in 13 quarters. The position peaked at $35.4M in Q3 2016. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

  • Palo Alto Investors reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
  • Palo Alto Investors sold 2,682,017 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $33.4M.
  • Palo Alto Investors first reported a position in Ariad Pharmaceuticals Inc in Q4 2013 and held it in 13 quarters.
  • Palo Alto Investors's Ariad Pharmaceuticals Inc position peaked at $35.4M in Q3 2016.
  • 1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on Palo Alto Investors's 13F filing for Q1 2017, filed 15 May 2017.